Application of MRI Water-Fat Separation Technology in Patients with Multiple Myeloma.
10.19746/j.cnki.issn.1009-2137.2022.01.030
- Author:
Ya-Wen GU
1
;
Ying WU
1
;
Rui-Xin YAN
2
;
Xiao-Na JIANG
1
;
Xiao-Yan JU
1
;
Xue SHI
1
;
Xian-Qi FENG
1
;
Wei WANG
3
Author Information
1. Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.
2. Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.
3. Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China,E-mail: 18661807392@163.com.
- Publication Type:Journal Article
- Keywords:
fat fraction;
magnetic resonance imaging;
multiple myeloma;
water-fat separation
- MeSH:
Humans;
Magnetic Resonance Imaging;
Multiple Myeloma/diagnostic imaging*;
Technology;
Water
- From:
Journal of Experimental Hematology
2022;30(1):183-188
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinical significance of magnetic resonance imaging water-fat separation (Dixon) technique in patients with multiple myeloma.
METHODS:A total of 41 newly diagnosed patients with multiple myeloma who underwent Dixon in The Affiliated Hospital of Qingdao University from April 2019 to April 2021 were included in this study. Patients were divided into observation group and control group according to whether Dixon performance was normal or not. The differences of clinical data and fat fraction (FF) between the two groups were compared. The correlation between FF and clinical data, disease stages and differences before and after treatment were also compared. The receiver operator characteristic curve of patients was drawn to analyze the diagnostic value of FF combined with serum alkaline phosphatase for bone destruction in patients with multiple myeloma.
RESULTS:Among the 41 patients, there were 12 cases in the control group and 29 cases in the observation group. There was no significant difference in age and sex between the two groups. In the observation group, β2-microglobulin concentration and M protein were significantly higher than those in the control group, while serum alkaline phosphatase and FF were lower (P<0.05). In all 41 patients included in the study, there was a significant negative correlation between FF value and β2-microglobulin concentration (r=-0.57), and a significant positive correlation between FF value and serum alkaline phosphatase (r=0.31). After treatment, FF value increased, while myeloma cell percentage, β2-microglobulin concentration and M protein decreased in 11 patients who completed 4 cycles of chemotherapy, and the differences before and after treatment were statistically significant (P<0.05). The value of serum alkaline phosphatase combined with FF value in predicting bone destruction is higher than that of FF value or serum alkaline phosphatase alone.
CONCLUSION:Dixon's different imaging manifestations can reflect the severity of the disease. FF value is correlated with clinical examination results and R-ISS staging, and there is a significant difference before and after treatment. Serum alkaline phosphatase combined with FF value is better than two indicators alone in predicting bone destruction.
